Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research
• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored signi...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Coors, Marilyn E. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Statistical analysis to identify biomarkers for safety - Clark, Matthew ELSEVIER, 2018, an international journal on biomedical and psychosocial approaches, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:159 ; year:2016 ; day:1 ; month:02 ; pages:267-271 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.drugalcdep.2015.12.006 |
|---|
| Katalog-ID: |
ELV019394810 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019394810 | ||
| 003 | DE-627 | ||
| 005 | 20230623150913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drugalcdep.2015.12.006 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016012000009.pica |
| 035 | |a (DE-627)ELV019394810 | ||
| 035 | |a (ELSEVIER)S0376-8716(15)01821-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.39 |2 bkl | ||
| 100 | 1 | |a Coors, Marilyn E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| 264 | 1 | |c 2016 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. | ||
| 650 | 7 | |a Adolescents with substance use disorder |2 Elsevier | |
| 650 | 7 | |a Biobanks |2 Elsevier | |
| 650 | 7 | |a Understanding |2 Elsevier | |
| 650 | 7 | |a Informed consent |2 Elsevier | |
| 650 | 7 | |a Genomic |2 Elsevier | |
| 650 | 7 | |a Assent |2 Elsevier | |
| 700 | 1 | |a Raymond, Kristen M. |4 oth | |
| 700 | 1 | |a Hopfer, Christian J. |4 oth | |
| 700 | 1 | |a Sakai, Joseph |4 oth | |
| 700 | 1 | |a McWilliams, Shannon K. |4 oth | |
| 700 | 1 | |a Young, Susan |4 oth | |
| 700 | 1 | |a Mikulich-Gilbertson, Susan K. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Clark, Matthew ELSEVIER |t Statistical analysis to identify biomarkers for safety |d 2018 |d an international journal on biomedical and psychosocial approaches |g Amsterdam [u.a.] |w (DE-627)ELV000553670 |
| 773 | 1 | 8 | |g volume:159 |g year:2016 |g day:1 |g month:02 |g pages:267-271 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.drugalcdep.2015.12.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
| 936 | b | k | |a 44.39 |j Toxikologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 159 |j 2016 |b 1 |c 0201 |h 267-271 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m e c me mec |
|---|---|
| matchkey_str |
coorsmarilyneraymondkristenmhopferchrist:2016----:dlsetwtsbtnesdsreadsetosneprclaannesadnb |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.38 44.39 |
| publishDate |
2016 |
| allfields |
10.1016/j.drugalcdep.2015.12.006 doi GBVA2016012000009.pica (DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Coors, Marilyn E. verfasserin aut Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier Raymond, Kristen M. oth Hopfer, Christian J. oth Sakai, Joseph oth McWilliams, Shannon K. oth Young, Susan oth Mikulich-Gilbertson, Susan K. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 https://doi.org/10.1016/j.drugalcdep.2015.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 159 2016 1 0201 267-271 5 045F 610 |
| spelling |
10.1016/j.drugalcdep.2015.12.006 doi GBVA2016012000009.pica (DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Coors, Marilyn E. verfasserin aut Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier Raymond, Kristen M. oth Hopfer, Christian J. oth Sakai, Joseph oth McWilliams, Shannon K. oth Young, Susan oth Mikulich-Gilbertson, Susan K. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 https://doi.org/10.1016/j.drugalcdep.2015.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 159 2016 1 0201 267-271 5 045F 610 |
| allfields_unstemmed |
10.1016/j.drugalcdep.2015.12.006 doi GBVA2016012000009.pica (DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Coors, Marilyn E. verfasserin aut Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier Raymond, Kristen M. oth Hopfer, Christian J. oth Sakai, Joseph oth McWilliams, Shannon K. oth Young, Susan oth Mikulich-Gilbertson, Susan K. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 https://doi.org/10.1016/j.drugalcdep.2015.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 159 2016 1 0201 267-271 5 045F 610 |
| allfieldsGer |
10.1016/j.drugalcdep.2015.12.006 doi GBVA2016012000009.pica (DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Coors, Marilyn E. verfasserin aut Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier Raymond, Kristen M. oth Hopfer, Christian J. oth Sakai, Joseph oth McWilliams, Shannon K. oth Young, Susan oth Mikulich-Gilbertson, Susan K. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 https://doi.org/10.1016/j.drugalcdep.2015.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 159 2016 1 0201 267-271 5 045F 610 |
| allfieldsSound |
10.1016/j.drugalcdep.2015.12.006 doi GBVA2016012000009.pica (DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Coors, Marilyn E. verfasserin aut Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier Raymond, Kristen M. oth Hopfer, Christian J. oth Sakai, Joseph oth McWilliams, Shannon K. oth Young, Susan oth Mikulich-Gilbertson, Susan K. oth Enthalten in Elsevier Science Clark, Matthew ELSEVIER Statistical analysis to identify biomarkers for safety 2018 an international journal on biomedical and psychosocial approaches Amsterdam [u.a.] (DE-627)ELV000553670 volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 https://doi.org/10.1016/j.drugalcdep.2015.12.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ 44.39 Toxikologie VZ AR 159 2016 1 0201 267-271 5 045F 610 |
| language |
English |
| source |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 |
| sourceStr |
Enthalten in Statistical analysis to identify biomarkers for safety Amsterdam [u.a.] volume:159 year:2016 day:1 month:02 pages:267-271 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Pharmakologie Toxikologie |
| institution |
findex.gbv.de |
| topic_facet |
Adolescents with substance use disorder Biobanks Understanding Informed consent Genomic Assent |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Statistical analysis to identify biomarkers for safety |
| authorswithroles_txt_mv |
Coors, Marilyn E. @@aut@@ Raymond, Kristen M. @@oth@@ Hopfer, Christian J. @@oth@@ Sakai, Joseph @@oth@@ McWilliams, Shannon K. @@oth@@ Young, Susan @@oth@@ Mikulich-Gilbertson, Susan K. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000553670 |
| dewey-sort |
3610 |
| id |
ELV019394810 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019394810</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2015.12.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019394810</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(15)01821-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coors, Marilyn E.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adolescents with substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biobanks</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Understanding</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Informed consent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genomic</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Assent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raymond, Kristen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hopfer, Christian J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakai, Joseph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McWilliams, Shannon K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Young, Susan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mikulich-Gilbertson, Susan K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:159</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:267-271</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2015.12.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">159</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0201</subfield><subfield code="h">267-271</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Coors, Marilyn E. |
| spellingShingle |
Coors, Marilyn E. ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| authorStr |
Coors, Marilyn E. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000553670 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent Elsevier |
| topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent |
| topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent |
| topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.38 bkl 44.39 Elsevier Adolescents with substance use disorder Elsevier Biobanks Elsevier Understanding Elsevier Informed consent Elsevier Genomic Elsevier Assent |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k m r km kmr c j h cj cjh j s js s k m sk skm s y sy s k m g skm skmg |
| hierarchy_parent_title |
Statistical analysis to identify biomarkers for safety |
| hierarchy_parent_id |
ELV000553670 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Statistical analysis to identify biomarkers for safety |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000553670 |
| title |
Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| ctrlnum |
(DE-627)ELV019394810 (ELSEVIER)S0376-8716(15)01821-9 |
| title_full |
Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| author_sort |
Coors, Marilyn E. |
| journal |
Statistical analysis to identify biomarkers for safety |
| journalStr |
Statistical analysis to identify biomarkers for safety |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
267 |
| author_browse |
Coors, Marilyn E. |
| container_volume |
159 |
| physical |
5 |
| class |
610 610 DE-600 610 VZ 15,3 ssgn PHARM DE-84 fid 44.38 bkl 44.39 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Coors, Marilyn E. |
| doi_str_mv |
10.1016/j.drugalcdep.2015.12.006 |
| dewey-full |
610 |
| title_sort |
adolescents with substance use disorder and assent/consent: empirical data on understanding biobank risks in genomic research |
| title_auth |
Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| abstract |
• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. |
| abstractGer |
• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. |
| abstract_unstemmed |
• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
| title_short |
Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research |
| url |
https://doi.org/10.1016/j.drugalcdep.2015.12.006 |
| remote_bool |
true |
| author2 |
Raymond, Kristen M. Hopfer, Christian J. Sakai, Joseph McWilliams, Shannon K. Young, Susan Mikulich-Gilbertson, Susan K. |
| author2Str |
Raymond, Kristen M. Hopfer, Christian J. Sakai, Joseph McWilliams, Shannon K. Young, Susan Mikulich-Gilbertson, Susan K. |
| ppnlink |
ELV000553670 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.drugalcdep.2015.12.006 |
| up_date |
2024-07-06T21:20:23.830Z |
| _version_ |
1803866156649414656 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019394810</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623150913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.drugalcdep.2015.12.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016012000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019394810</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0376-8716(15)01821-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.39</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coors, Marilyn E.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adolescents with substance use disorder and assent/consent: Empirical data on understanding biobank risks in genomic research</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Customized disclosure(CD) improved understanding in addicted adolescents(AA) (p =0.002). • CD improved understanding in parents of AA(p =0.006) and siblings of former AA (p =0.034). • Understanding of standard disclosure (SD) in AA v controls differed (p =0.005). • Groups receiving CD scored significantly higher. • Understanding of SD plus CD in AA versus controls did not different significantly.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Adolescents with substance use disorder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biobanks</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Understanding</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Informed consent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genomic</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Assent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raymond, Kristen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hopfer, Christian J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakai, Joseph</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McWilliams, Shannon K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Young, Susan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mikulich-Gilbertson, Susan K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Clark, Matthew ELSEVIER</subfield><subfield code="t">Statistical analysis to identify biomarkers for safety</subfield><subfield code="d">2018</subfield><subfield code="d">an international journal on biomedical and psychosocial approaches</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000553670</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:159</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:267-271</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.drugalcdep.2015.12.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.39</subfield><subfield code="j">Toxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">159</subfield><subfield code="j">2016</subfield><subfield code="b">1</subfield><subfield code="c">0201</subfield><subfield code="h">267-271</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398508 |